NEW YORK Fera Pharmaceuticals has acquired rights to an investigational drug for treating a rare fungal ear infection, Fera said Wednesday. Fera announced the acquisition of itraconazole topical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback